Cargando…
Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects
BACKGROUND: CVD in obesity and T2DM are associated with endothelial activation, elevated plasma vascular inflammation markers and a prothrombotic state. We examined the contribution of FFA to these abnormalities following a 48-hour physiological increase in plasma FFA to levels of obesity and diabet...
Autores principales: | Mathew, Manoj, Tay, Eric, Cusi, Kenneth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837624/ https://www.ncbi.nlm.nih.gov/pubmed/20158910 http://dx.doi.org/10.1186/1475-2840-9-9 |
Ejemplares similares
-
A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018) -
Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma
por: Teo, Andrew, et al.
Publicado: (2023) -
Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase
por: Litzman, Jiří, et al.
Publicado: (2019) -
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
por: Croyal, Mikaël, et al.
Publicado: (2022) -
Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
por: Mairuhu, ATA, et al.
Publicado: (2005)